# Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury

> **NCT03296761** · — · UNKNOWN · sponsor: **Jingyuan,Xu** · enrollment: 70 (estimated)

## Conditions studied

- Evaluate the Correlation Between the Level of ESM-1 and the Prognosis of the Patients With ARDS

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03296761
- **Lead sponsor:** Jingyuan,Xu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2017-12-20
- **Final completion:** 2018-02-20
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296761, "Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03296761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*